Latest filing published 13 Oct 2026 for GSK plc, €1,328.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Hal Barron: trading record in brief
All filings by Hal Barron on record concern GSK plc. In total, 5 filings cover trades dated from 20 December 2022 to 9 October 2026.
The open-market side counts 1 purchase for €15k alongside 1 sale for €2.8M. Netting one side against the other leaves €2.8M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants.
The record was last updated on 13 October 2026 with a share grant (€1,328) in GSK plc. The last purchase on record was published on 21 December 2022, which is 1,419 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 4 days. The regulation allows three business days to notify a trade (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hal Barron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 32 shares@ US$46.58840.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:fe129b5b-39a4-4da0-bd8a-e8ab0eeb5493-15
- 73 shares@ US$49.52New York Stock Exchange (XNYS)ISIN US37733W2044RNS:9728220-3Canonical exit: 12 Nov 2026 (T+90)
- 73 shares@ US$49.520.0000% mcap0.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:71be54a6-2b7c-42c7-8a25-270569e580f5-3
- 107,377 shares0N/AISIN US37733W2044RNS:5066290-25
- 57,716 shares@ £41.84100.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5066290-26
5 of 5 declarations
